AFAP1 and carcinoma: Esfandi et al. [126] evaluated the clinical value of lncRNA AFAP1-AS1 in gastric cancer and confirmed that AFAP1-AS1 is down-regulated in gastric cancer compared to para-carcinoma tissues, and could therefore, be used as a diagnostic biomarker.